# 



## 

||**Page**|
|---|---|
|**Report of the Trustees**||
|**• Reference and Administrative Information**|**1**|
|**• Letter from the Chairman**|**2**|
|**• Trustees Report**|**3**|
|**Report of the Independent Auditors**|**11**|
|**Statement of Financial Activities**|**14**|
|**Balance Sheet**|**15**|
|**Cashflow**|**16**|
|**Notes to the Financial Statements**|**17**|





## 

## 

## 

|David Pardoe (Chair)||
|---|---|
|Victoria Bracey (Vice Chair)||
|Carl Broadbridge|(Appointed 26 May 2021)|
|Jo Broom||
|Ian Downie||
|Andy Hall|(Retired 3 November 2021)|
|Peter Hill||
|Mark Merrill||
|Michael Nielsen|(Appointed 26 May 2021)|
|Nicola Spicer||
|Stella Sykes||





## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

||**For the year ended 31 **|**For the year ended 31 **|**March 2022**||||
|---|---|---|---|---|---|---|
||||||2022|2021|
|||Unrestricted|Designated|Restricted|Total|Total|
||Note||||||
|**Income and Endowments from:**|||||||
|**Donations and legacies**|||||||
|Donations|2|602,563||95,432|697,995|679,911|
|Legacies||. 316,568||1,647|318,215|1,287,587|
|Coronavirus Job Retention Scheme||||−||10,257|
|**Other trading activities**|3||||||
|Fundraising||448,236|||448,236|419,726|
|Trading activities||22,444|||22,444|19,644|
|**Investment**|**4**|94,155|||94,155|87,333|
|**Other**||1,287||−|1,287|2,031|
|**TOTAL INCOME AND ENDOWMENTS**||1,485,253||97,079|1,582,332|2,506,489|
|**Expenditure on:**|||||||
|**Raising funds**|5||||||
|Fundraising||304,474|||304,474|289,005|
|Trading expenses||6,486|||6,486|6,568|
|Investment Management costs||5,765|||5,765|5,132|
|**Charitable activities**|6||||||
|Grant for Hospice costs||1,267,699||19,044|1,286,743|1,014,842|
|Administration costs||91,902|||91,902|90,657|
|**TOTAL EXPENDITURE**||1,676,326||19,044|1,695,370|1,406,204|
|**NET INCOME/(EXPENDITURE) FOR THE YEAR**|||||||
|**BEFORE GAINS AND LOSSES ON INVESTMENTS**||(191,073)||78,035|(113,038)|1,100,285|
|Net gain/(losses) on investments|||||||
|Realised|||||||
|Unrealised|12|72,525|||72,525|351,973|
|||72,525|||72,525|351,973|
|**NET INCOME/(EXPENDITURE)**||(118,548)||78,035|(40,513)|1,452,258|
|**TRANSFER BETWEEN FUNDS**|||||||
|**NET MOVEMENT IN FUNDS**||(118,548)|−|78,035|(40,513)|1,452,258|
|**RECONCILIATION OF FUNDS**|||||||
|Total funds brought forward|||||||
|at 1 April 2021||3,573,394||203,887|3,777,281|2,325,023|
|**Total funds carried forward as at 31 March 2022**||3,454,846||281,922|3,736,768|3,777,281|





## 

## 

|||2022|2021|
|---|---|---|---|
||Note|£|£|
|**Fixed assets**||||
|Tangible fixed assets|11|3,466|5,063|
|Investments|12|2,686,233|2,134,878|
|||2,689,699|2,139,941|
|**Current assets**||||
|Stock|13|1,243|344|
|Debtors|14|159,049|1,032,718|
|Deposits||853,352|346,489|
|Cash at bank and in hand||147,705|304,567|
|||1,161,348|1,684,118|
|**Creditors: amounts due within one year**|15|(114,279)|(46,778)|
|**NET CURRENT ASSETS**||1,047,069|1,637,340|
|**TOTAL ASSETS LESS CURRENT LIABILITIES**||3,736,768|3,777,281|
|**Funds**||||
|Unrestricted funds|17|3,454,844|3,573,394|
|Designated funds|18||−|
|Restricted funds|19|281,924|203,887|
|||3,736,768|3,777,281|





## 

## 

|||2022|2021|
|---|---|---|---|
||**Note**|£|£|
|**Cash flows from operating activities:**||||
|**Net cash provided by (used in) operating activities**|a|738,140|63,816|
|**Cash flows from investing activities:**||||
|Investment and Interest income received||94,155|87,333|
|Purchase o f property, plant and equipment||(3,464)|(1,638)|
|Proceeds from sale of investments||||
|Purchase of investments||(478,830)||
|**Net cash provided by investing activities**||(388,139)|85,695|
|Increase/(decrease) in cash and cash equivalents in the year||350,001|149,511|
|Cash and cash equivalents at the beginning o f the year||651,056|501,545|
|**Cash at bank and in hand**|b|1,001,057|651,056|
|||2022|2021|
|||£|£|
|**a) Reconciliation of net income/(expenditure) to net cash flow from operating activities**||||
|Net income/(expenditure) for the year (as per the statement o f financial activities)||(40,513)|1,452,258|
|Adjustments for:||||
|Depreciation||5,063|6,648|
|(Gains)/losses on investments||(72,525)|(351,973)|
|Investments and Interest income||(94,155)|(87,333)|
|(Increase)/decrease in stocks||(899)|245|
|(Increase)/decrease in debtors||873,669|(944,999)|
|Increase/(decrease) in creditors||67,500|(11,030)|
|||738,140|63,816|
|**b) Analysis of cash and cash equivalents**||||
|||2022|2021|
|||£|£|
|Cash at bank and in hand||1,001,057|651,056|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

|**Income from donations**|||||
|---|---|---|---|---|
||||Total|Total|
||Unrestricted|Restricted|2022|2021|
||£|£|£|£|
|Individuals|159,044|10,180|169,224|150,409|
|In Memoriam|140,521|6,165|146,686|160,907|
|Organisations and Trusts|302,848|79,087|381,935|368,445|
|Donated services|150||150|150|
|||−|||
||602,563|95,432|697,995|679,911|



||||Total|
|---|---|---|---|
||Unrestricted|Restricted|2021|
||£|£|£|
|Individuals|150,179|230|150,409|
|In Memoriam|159,302|1,605|160,907|
|Organisations and Trusts|339,755|28,690|368,445|
|Donated services|150||150|
|||−||
||649,386|30,525|679,911|





## 

## 

## 

|**Income from other trading ac**|**tivities**||||
|---|---|---|---|---|
||||Total|Total|
||Unrestricted|Restricted|2022|2021|
||f|f|f|f|
|Fundraising|265,793||265,793|419,726|
|Hospice Lottery|182,443||182,443||
||448,236||448,236|419,726|
|Sales of Christmas cards|22,444||22,444|19,644|
||470,680||470,680|439,370|



||||Total|
|---|---|---|---|
||Unrestricted|Restricted|2021|
||f|f|f|
|Fundraising|419,726||419,726|
|Sales of Christmas cards|19,644||19,644|
||439,370||439t370|



## 

|**Investment Income**|||||
|---|---|---|---|---|
||||Total|Total|
||Unrestricted|Restricted|2022|2021|
||f|f|f|f|
|Investment Income|91,390||91,390|85,986|
|Bank Interest|2,765||2,765|1,347|
||94,155||94,155|87,333|





## 

## 

|**5.**|**Analysis of expenditure on raising funds**|||||||
|---|---|---|---|---|---|---|---|
|||||||Total|Total|
||||Staff Costs|Costs|Depreciation|2022|2021|
||||E|E|E|E|E|
||Fundraising||235,412|69,062||304,474|289,005|
||Cost of goods for resale|||6,486||6,486|6,568|
||Investment Management costs|||5,765||5,765|5,132|
||||235,412|81,313||316,725|300,705|
|**6.**|**Analysis of expenditure on charitable activities**|||||||
|||||||Total|Total|
|||Note|Staff Costs|Costs|Depreciation|2022|2021|
||||E|_E_|E|E|_E_|
||Grant for Hospice clinical expenses|||1,250,000||1,250,000|950,000|
||Grant for Hospice at Home clinical expenses|||14,583||14,583|35,050|
||Grant for Hospice non−clinical expenses (training etc)|||22,160||22,160|29,792|
|||||1,286,743||1,286,743|1,014,842|
||Depreciation||||5,063|5,063|6,648|
||Support costs|7|45,905|34,190||80,095|65,877|
||Governance costs|7||6,744||6,744|18,132|
||||45,905|1,327,677|5,063|1,378,645|1,105,499|
||Total expenditure (notes Sand 6)|||||1,695,370|1,406,204|
|**7.**|**Analysis of administration costs**|||||||
||||General<br>support|Governance<br>function|Total<br>2022|Basis of<br>apportionment|2021|
||||E|E|E||E|
||General office||29,278|−|29,278|Invoice|25,772|
||Trustee meeting expenses|||1,624|1,624|Invoice|1,699|
||Salaries, wages and related costs||40,105|2,305|42,410|Allocated on time|42,410|
||Auditors' remuneration|||5,120|5,120|Governance|5,560|
||Consultancy fees|||3,480|3,480|Governance|1,295|
||Legal fees||−|4,927|4,927|Governance|7,273|
||Depreciation||5,063||5,063||6,648|
||||74,446|17,456|91,902||90,657|





## 

## 

|**8.**|**Net Incoming Resources for the Year**<br>This is stated after charging:|||
|---|---|---|---|
|||2022|2021|
||Depreciation|5,063|6,648|
||Auditors remuneration:|||
||−audit|5,120|5,560|
|**9.**|**Staff Costs and Numbers**|||
||Staff costs were as follows:|||
|||2022|2021|
||Salaries and wages|254,190|263,112|
||Social security costs|14,942|14,391|
||Pension costs|12,185|10,844|
|||281,317|288,347|



||2022|2021|
|---|---|---|
||No.|No.|
|Fundraising/Administration|13|12|
|The average full time equivalent number of employees during the year was as follows:|||
||2022|2021|
||No.|No.|
|Fundraising/Administration|10|9|



## 



|**11. **|**For th**<br> **Tangible Fixed Assets**|**e year ended 31 March 2022**|||
|---|---|---|---|---|
|||Office|Computer||
|||equipment|equipment|Total|
|||E|E|E|
||**Cost**||||
||At 1 April 2021|23,763|12,570|36,333|
||Additions||3,464|3,464|
||Disposals||−|−|
||At 31 March 2022|23,763|16,034|39,797|
||**Depreciation**||||
||At 1 April 2021|21,090|10,178|31,268|
||Charge for the year|2,063|3,000|5,063|
||Eliminated on disposals|−|−|−|
||At 31 March 2022|23,153|13,178|36,331|
||**Net book value**||||
||At 31 March 2022|610|2,856|3,466|
||At 31 March 2021|2,673|2,392|5,065|
|**12. **|**Fixed Asset Investments**||||
|||||Total|
|||||E|
||Valuation at 1 April 2021|||2,134,878|
||Additions|||478,830|
||Disposals|||−|
||Revaluations|||72,525|
||Valuation as at 31 March 2022|||2,686,233|
|**13. **|**Stock**||||
||||2022|2021|
||||E|E|
||Stock **for** resale||1,243|344|
|**14. **|**Debtors**||||
||||2022|2021|
||||E|E|
||Trade debtors||54,470|72,538|
||Prepayments and accrued income||19,551|19,820|
||Gift Aid||1,769|5,267|
||Legacies||83,259|935,093|
||||159,049|1,032,718|
|**15. **|**Creditors: amounts due within one year**||||
||||2022|2021|
||||E|E|
||Trade creditors||64,854|9,137|
||PAYE and National Insurance||4,937|4,594|
||Other creditors||10,758|10,758|
||Pension contributions paid over after 31 March||444|1,711|
||Accruals and deferred income||18,703|20,578|
||||99,697|46,778|
|**16. **|**Operating Lease Commitments**||||
||As at 31 March the charity had total future minimum lease payments under non−cancellable operating leases as follows:||||
||||Land and buildings||
||||2022|2021|
||||E|E|
||Less than 1 year||||
||||Equipment||
||||2022|2021|
||||E|E|
||Less than 1 year||5,891|9,257|
||||5,891|9,257|



## 

## 

## 

## 



||||**For the year ended 31 March 2022**|**For the year ended 31 March 2022**|||
|---|---|---|---|---|---|---|
|**18.**|**Designated Funds**||||||
|||Balance at|Incoming|Outgoing||Balance at|
|||1.4.21|resources|resources|Transfers in/(out)|31.3.22|
||Hospice at Home Fund||||||
||_Analysis o f movements in Unrestricted Funds −previous_||_year_||||
|||Balance at|Incoming|Outgoing||Balance at|
|||1.4.20|resources|resources|Transfers in/(out)|31.3.21|
||Hospice at Home Fund|320,448|||(320,448)||
|||320,448|||(320,448)||



## 

## 

||Balance|at|Incoming|Outgoing||Balance at|
|---|---|---|---|---|---|---|
||1.4.21||resources|resources|Transfers in/(out)|31.3.22|
|Children's Bereavement Fund|18,847|||||18,847|
|Staff Fund||1,246|3,390|(1,401)||3,235|
|PGSC Fund|145,951||10,050|||156,001|
|Equipment Fund||6,209||(425)||5,784|
|Training and Development of|||||||
|nursing staff at the hospice||4,600|4,125|(2,050)||6,675|
|Hospice at Home Fund|23,798||23,504|(15,168)||32,134|
|Hospice Garden Fund||3,236||||3,236|
|Hospice Treatment Room Fund|||56,012|||56,012|
||203,887||97,081|(19,044)||281,924|
|_Analysis o f movements in Restricted Funds −previous year_|||||||
||Balance|at|Incoming|Outgoing||Balance at|
||1.4.20||resources|resources|Transfers in/(out)|31.3.21|
|Children's Bereavement Fund|18,984||−|(137)||18,847|
|Staff Fund||451|890|(95)||1,246|
|PGSC Fund|||158,922|(12,971)||145,951|
|Equipment Fund||2,465|4,690|(946)||6,209|
|Training and Development of|||||||
|nursing staff at the hospice||4,050|7,000|(6,450)||4,600|
|Hospice at Home Fund|39,583||19,215|(35,000)||23,798|
|Hospice Garden Fund||5,226|250|(2,240)||3,236|
||70,759||190,967|(57,839)||203,887|



## 

## 



## 

## 

## 

## 

## 

## 

## 

|In 2021/22 the fund received the following grant.||
|---|---|
|Wessex GP Educational Trust|4,125|



## 

## 

||Screwfix Foundation|10,000||||
|---|---|---|---|---|---|
||HSBC −Supporting our Communities|18,642||||
||B & Q Foundation|5,000||||
||The Morrisons Foundation|22,370||||
|**20. **|**Analysis of Net Assets between Funds**|||||
|||Unrestricted|Designated|Restricted|Total|
|||**£**|**£**|**f**|E|
||Fixed assets|2,407,776||281,923|2,689,699|
||Net current assets|1,047,069|||1,047,069|
||**Net assets at the end of the year**|3,454,845||281,923|3,736,768|



## 



## 

## 

|||||2021|
|---|---|---|---|---|
||Unrestricted|Designated|Restricted|Total|
||£|£|£|£|
|**Income and Endowments from:**|||||
|**Donations and legacies**|||||
|Donations|649,386||30,525|679,911|
|Legacies|1,127,145||160,442|1,287,587|
|Coronavirus Job Retention Scheme|10,257||−|10,257|
|**Other trading activities**|||||
|Fundraising|419,726|||419,726|
|Trading activities|19,644|||19,644|
|**Investment**|87,333|||87,333|
|**Other**|2,031|||2,031|
|**TOTAL INCOME AND ENDOWMENTS**|2,315,522||190,967|2,506,489|
|**Expenditure on:**|||||
|**Raising funds**|||||
|Fundraising|289,005|||289,005|
|Trading expenses|6,568|||6,568|
|Investment Management costs|5,132|||5,132|
|**Charitable activities**|||||
|Grant for Hospice costs|957,003||57,839|1,014,842|
|Administration costs|90,657||−|90,657|
|**TOTAL EXPENDITURE**|1,348,365||57,839|1,406,204|
|**NET INCOME/(EXPENDITURE) FOR THE YEAR**|||||
|**BEFORE GAINS AND LOSSES ON INVESTMENTS**|967,157||133,128|1,100,285|
|Net gain/(losses) on investments|||||
|Realised|||||
||−|||−|
|Unrealised|351,973|||351,973|
||351,973|||351,973|
|**NET INCOME/(EXPENDITURE)**|1,319,130||133,128|1,452,258|
|**TRANSFER BETWEEN FUNDS**|320,448|(320,448)|||
|**NET MOVEMENT IN FUNDS**|1,639,578|(320,448)|133,128|1,452,258|
|**RECONCILIATION OF FUNDS**|||||
|Total funds brought forward|||||
|at 1 April 2020|1,933,816|320,448|70,759|2,325,023|
|**Total funds carried forward as at 31 March 2021**|3,573,394||203,887|3,777,281|



